Transfusion monitoring during anesthesia
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This trial looks at patients who received a drug or product to help with bleeding (hemostasis) during anesthesia. It aims to understand how these products are used and if they are safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have received a medicine or product to control bleeding (called a hemostasis product).
- You must agree to allow your medical data to be used for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized approach to managing your own blood during surgery, which may reduce the need for donor blood transfusions. It is for people having planned non-cardiac surgery expected to need a large amount of blood.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
This trial tests a method to control bleeding during open heart surgery. It may help you if you are planning to have this surgery.
This study looks at how managing blood products during heart surgery with a heart-lung machine affects the risk of red blood cell breakdown in children. The goal is to find safer ways to handle blood during these procedures.
This trial tests whether an allergy medicine (chlorpheniramine) can prevent allergic reactions during blood transfusions. You might be placed in either the medicine group or a placebo (inactive pill) group to compare side effects and reaction rates.
This study is testing whether giving blood transfusions during surgery based on a certain hemoglobin level is safe and effective. It may help doctors decide the best time to transfuse during major surgery.
Hear when a new Transfusion Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.